Results per Page:
Making memories with Shingrix
From the Ford and Koelle labs of the Cancer Consortium, in collaboration with the Benaroya Research Institute
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection
Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
El momento en que se administra la TAR para el VIH es más importante de lo que imaginábamos
De los grupos de los doctores Edlefsen y Frenkel, Consorcio Oncológico
In the crosshairs: herpesvirus 6B as a potential cause of idiopathic pneumonia
From the Hill and Boeckh groups, Vaccine and Infectious Disease and Clinical Research Divisions
Switching from KSHV latency to lytic replication
From the Geballe lab, Human Biology Division & Cancer Consortium
A new take on having skin in the game
From the Zhu lab, Vaccine and Infectious Disease Division
Researchers refine experimental gene therapy for herpes
Treatment sharply reduced viral shedding in laboratory mice
A unique population of mucosal Tregs respond to local viral infection
From the Lund and Prlic labs, Vaccine and Infectious Disease Division
Sleuthing the immune system’s mysterious T-regs
Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
A cure for herpes? There is progress to report
Mouse studies show gene therapy can cause big drop in latent infections
¿La cura del herpes? Hay avances que reportar
Los estudios con ratones muestran que la terapia génica puede reducir muchísimo las infecciones inactivas
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Dr. Joshua Hill receives Amy Strelzer Manasevit grant award
Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections
Stealing a secret from an unwelcome virus
An unexpected discovery in a herpes lab might bring relief to cancer patients
Experimental herpes drug pritelivir more effective than standard treatment
Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows
Can gene editing cure herpes?
Fred Hutch study shows ‘pathway to potential cure’ for herpes simplex and other latent viruses